IDEXX LABORATORIES INC /DE Secured Long-term Debt, Noncurrent
IDEXX LABORATORIES INC /DE (IDXX) had Secured Long-term Debt, Noncurrent of $899.56 million as of 2020-06-30, per its 10-Q filed 2020-07-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:SecuredLongTermDebt · last filed 2020-07-31
- 2020-06-30: Secured Long-term Debt, Noncurrent $899.56M.
- 2020-03-31: Secured Long-term Debt, Noncurrent $697.36M.
- 2019-12-31: Secured Long-term Debt, Noncurrent $698.91M.
- 2019-09-30: Secured Long-term Debt, Noncurrent $696.63M.
| Period end | Secured Long-term Debt, Noncurrent |
|---|---|
| 2020-06-30 | $899.56M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $697.36M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $698.91M 10-Q · filed 2020-07-31 |
| 2019-09-30 | $696.63M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $700.55M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $699.33M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $601.35M 10-K · filed 2020-02-14 |
| 2018-09-30 | $602.42M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $603.13M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $609.00M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $606.08M 10-K · filed 2019-02-15 |
| 2017-09-30 | $604.15M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $600.89M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $594.87M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $593.11M 10-K · filed 2018-02-16 |
| 2016-09-30 | $599.14M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $597.96M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $600.02M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $597.09M 10-K · filed 2017-02-17 |
| 2015-09-30 | $599.56M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $598.92M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $500.00M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $350.00M 10-K · filed 2016-02-17 |
| 2014-09-30 | $350.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $150.00M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $150.09M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $150.36M 10-K · filed 2015-02-17 |
| 2013-09-30 | $624.00K 10-Q · filed 2013-10-22 |
| 2013-06-30 | $884.00K 10-Q · filed 2013-07-23 |
| 2013-03-31 | $1.14M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $1.39M 10-K · filed 2014-02-18 |
| 2012-09-30 | $1.78M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $2.02M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $2.26M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $2.50M 10-K · filed 2013-02-19 |
| 2011-09-30 | $2.73M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $2.97M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $3.19M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $3.42M 10-K · filed 2012-02-17 |
| 2010-09-30 | $3.64M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $3.86M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $4.28M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |